
Video Ad Feedback
Senate investigation: drugmaker harmed patients, profited, with asthma inhaler switch
In 2024, doctors and parents scrambled to find an affordable asthma inhaler after drugmaker GSK pulled the popular Flovent off the market. A senator launched an investigation to find out what happened, sharing her findings exclusively with CNN.
4:09
• Source:
CNN
Health
8 videos

Video Ad Feedback
Senate investigation: drugmaker harmed patients, profited, with asthma inhaler switch

Video Ad Feedback
Can I fix my frazzled attention span? Here's how my 30-day training worked

Video Ad Feedback
Scientists discover how 'super agers' stay mentally sharp

Video Ad Feedback
Former CDC official: 'Very concerned' about Trump's surgeon general pick

Video Ad Feedback
There's a shortage of estrogen patches. A board certified gynecologist shares her advice.

Video Ad Feedback
MAHA mom "outraged" at Trump's order on weed killer

Video Ad Feedback
"We're going to make the prices fair": Dr. Oz joins CNN to discuss newly launched "Trump Rx" site for prescription medicine




